BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8291097)

  • 1. Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation.
    Pi F; Hotter G; Closa D; Roselló-Catafau J; Bulbena O; Badosa F; Morris M; Fernández-Cruz L; Gelpi E
    Transplantation; 1994 Jan; 57(1):12-7. PubMed ID: 8291097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor antagonist enhances lung preservation in a canine model of single lung allotransplantation.
    Corcoran PC; Wang Y; Katz NM; Rajan SS; Analouei AR; Foegh ML; Wallace RB
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):66-72. PubMed ID: 1614217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation.
    Hotter G; Closa D; Pi F; Roselló-Catafau J; Bulbena O; Badosa F; Fernández-Cruz L; Gelpí E
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):135-43. PubMed ID: 8012760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
    Jancar S; Braquet P; Sirois P
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid mediator production in acute and chronic pancreatitis in the rat.
    Zhou W; Levine BA; Olson MS
    J Surg Res; 1994 Jan; 56(1):37-44. PubMed ID: 8277767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model.
    Castellvi J; Borobia FG; Figueras J; Fradera R; Herrero I; Torras J; Busquets J; Fabregat J; Jorba R; Jaurrieta E
    Transplant Proc; 2002 Feb; 34(1):50-2. PubMed ID: 11959181
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosanoid and inositol phosphate response to platelet-activating factor (PAF) and to a PAF antagonist in rat astroglial cells.
    Petroni A; Salami M; Blasevich M; Papini N; Galella G; Colombo C; Galli C
    Brain Res Dev Brain Res; 1994 Apr; 78(2):169-74. PubMed ID: 8026072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor antagonist enhances lung preservation.
    Corcoran PC; Wang Y; Katz NM; St Louis JD; Foegh ML; Rajan SS; Analouei AR; Wallace RB
    J Surg Res; 1992 Jun; 52(6):615-20. PubMed ID: 1528038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation.
    Hotter G; Closa D; Pi F; Prats N; Fernandez-Cruz L; Bulbena O; Gelpí E; Roselló-Catafau J
    Transplantation; 1995 Feb; 59(3):417-21. PubMed ID: 7871573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat.
    Liu XH; Eun BL; Silverstein FS; Barks JD
    Pediatr Res; 1996 Dec; 40(6):797-803. PubMed ID: 8947953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of preservation/reperfusion injury by platelet-activating factor antagonism in the rat liver graft.
    Minor T; Yamaguchi T; Isselhard W
    Transplant Proc; 1995 Feb; 27(1):522-3. PubMed ID: 7879086
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
    Filep JG; Braquet P; Mózes T
    Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
    Fletcher JR; DiSimone AG; Earnest MA
    Ann Surg; 1990 Mar; 211(3):312-6. PubMed ID: 2178565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF antagonist BN-52021 reduces intercellular adhesion molecule-1 expression and oxidative stress in rats with reperfusion damage due to unilateral testicular torsion.
    Ozturk H; Ozturk H; Yagmur Y
    Pediatr Surg Int; 2006 Feb; 22(2):191-6. PubMed ID: 16369775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the platelet-activating factor (PAF) antagonist, BN 52021, on free radical-induced intestinal ischemia-reperfusion damage in the rat.
    Droy-Lefaix MT; Drouet Y; Braquet P; Géraud G
    Adv Exp Med Biol; 1990; 264():419-22. PubMed ID: 2244522
    [No Abstract]   [Full Text] [Related]  

  • 17. Free radical enhancement promotes leucocyte recruitment through a PAF and LTB4 dependent mechanism.
    Hotter G; Closa D; Prats N; Pi F; Gelpí E; Roselló-Catafau J
    Free Radic Biol Med; 1997; 22(6):947-54. PubMed ID: 9034233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term lung preservation with the PAF antagonist BN 52021.
    Conte JV; Katz NM; Wallace RB; Foegh ML
    Transplantation; 1991 Jun; 51(6):1152-6. PubMed ID: 2048190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAF induces rat plasma extravasation and releases eicosanoids during anaphylaxis.
    Jancar S; Sirois MG; Carrier J; Braquet P; Sirois P
    Inflammation; 1991 Oct; 15(5):347-54. PubMed ID: 1757122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.